These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2930695)

  • 1. The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study.
    Tjandra JJ; Sacks NP; Thompson CH; Leyden MJ; Stacker SA; Lichtenstein M; Russell IS; Collins JP; Andrews JT; Pietersz GA
    Br J Cancer; 1989 Feb; 59(2):296-302. PubMed ID: 2930695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer.
    Tjandra JJ; Russell IS; Collins JP; Andrews JT; Lichtenstein M; Binns D; McKenzie IF
    Cancer Res; 1989 Mar; 49(6):1600-8. PubMed ID: 2647290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoscintigraphy for detection of lymph node metastases from breast cancer.
    Thompson CH; Lichtenstein M; Stacker SA; Leyden MJ; Salehi N; Andrews JT; McKenzie IF
    Lancet; 1984 Dec; 2(8414):1245-7. PubMed ID: 6150280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolymphscintigraphy of axillary lymph node metastases in breast cancer patients using monoclonal antibodies: first clinical findings.
    Mandeville R; Pateisky N; Philipp K; Kubista E; Dumas F; Grouix B
    Anticancer Res; 1986; 6(6):1257-63. PubMed ID: 3813482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoscintigraphy with 131I-labelled HMFG2 and HMFG1 F(ab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients.
    Athanassiou A; Pectasides D; Pateniotis K; Tzimis L; Natsis P; Lafi A; Arapantoni P; Koutsiouba P; Taylor-Papadimitriou J; Epenetos A
    Int J Cancer Suppl; 1988; 3():89-95. PubMed ID: 3209306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node identification in breast cancer patients.
    Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
    Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer.
    Straver ME; Loo CE; Alderliesten T; Rutgers EJ; Vrancken Peeters MT
    Br J Surg; 2010 Aug; 97(8):1226-31. PubMed ID: 20602508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.
    Donker M; Straver ME; Wesseling J; Loo CE; Schot M; Drukker CA; van Tinteren H; Sonke GS; Rutgers EJ; Vrancken Peeters MJ
    Ann Surg; 2015 Feb; 261(2):378-82. PubMed ID: 24743607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
    Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
    Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.
    Veronesi U; Paganelli G; Viale G; Galimberti V; Luini A; Zurrida S; Robertson C; Sacchini V; Veronesi P; Orvieto E; De Cicco C; Intra M; Tosi G; Scarpa D
    J Natl Cancer Inst; 1999 Feb; 91(4):368-73. PubMed ID: 10050871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolymphoscintigraphy in breast cancer: evaluation using 131I-labeled monoclonal antibody B72.3.
    Fig LM; Brown RS; von Moll L; Appelman HD; Stevens R; Harness J; August D; Sondak VK; Chang AE; Zasadny KR; Fisher SJ; Johnson JW; Wicha MS; Colcher D; Lichter AS; Wahl RL
    Nucl Med Biol; 1998 Apr; 25(3):251-60. PubMed ID: 9620631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of axillary lymph node ultrasound and large core biopsy in the preoperative assessment of patients selected for sentinel node biopsy.
    Nori J; Bazzocchi M; Boeri C; Vanzi E; Nori Bufalini F; Mangialavori G; Distante V; Masi A; Simoncini R; Londero V
    Radiol Med; 2005 Apr; 109(4):330-44. PubMed ID: 15883518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer.
    Agarwal A; Heron DE; Sumkin J; Falk J
    J Surg Oncol; 2005 Oct; 92(1):4-8. PubMed ID: 16180213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous 99mtechnetium mAb-170H.82 (Tru-Scint AD).
    Dessureault S; Koven I; Reilly RM; Couture J; Schmocker B; Damani M; Kirsh J; Ichise M; Sidlofsky S; McEwan AJ; Boniface G; Stern H; Gallinger S
    Breast Cancer Res Treat; 1997 Aug; 45(1):29-37. PubMed ID: 9285114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.